In fact, understanding of the kinetic parameters of GCK enzyme brought in new antidiabetic agents which have potential to fulfill the need for an optimum drug to control glucose levels efficiently with minimum side effects in the management of T2DM (27). Here, GCK is linked to type 2 diabetes mellitus.